Actively hiring
Regenerative Medicine
Cell & Gene Therapy
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$100k
3 rounds on record
Latest round
$100k
Convertible Note · Feb 2024 · 2 yr ago
Grants
$1.2M
2 grants · CORDIS
Backers
1
Longitude Capital
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 22, 2024
Raised a round Convertible Note $100k · SEC Form D
2024
Founded
Jul 1, 2021
Won a grant $1M · CORDIS
Oct 15, 2019
Won a grant $225k · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Feb 2024 | $100k | — | SEC Form D |
| Grant | Jul 2021 | $1M | — | CORDIS |
| Grant | Oct 2019 | $225k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | GENERATE TECHNOLOGIES INC. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
John KleinExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one

backs Modulari-T

backs Modulari-T
Similar startupsby what they do, their industry and backers

The Modulari-T science is two technologies in one system. MARC - Modular Actuation Receptor Complex and MoVe - Modular Vector.

Claris Bio is dedicated to advancing transformative therapies for sight-threatening conditions where limited or no treatment options exist.

AnteAGE® is a stem cell science research & development company dedicated to delivering advanced growth factor skincare products &…

Skyline Therapeutics is a fully integrated gene therapy company dedicated to the discovery, development and delivery of innovative…

Sabai exclusively focuses on ethical and biosafety reviews and support that leads with science and differentiates with service.

Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and…
News
Generate Postgres test data with no database
Paste your CREATE TABLE statements and generate referentially intact Postgres data. No database, no connection string, no config. Weavori's DDL paste mode runs from a schema file.
Read more
Report
Report
Generate Capital CEO David Crane on energy's market disconnect
CNBC's Brian Sullivan discusses with Generate Capital CEO David Crane why power stocks may be missing a historic demand opportunity. They also break down the cost of electricity, why Crane is bullish on solar, and why he believes a major nuclear buildout
Read more
Report
Using llama-cpp-python grammars to generate JSON
llama.cpp recently added the ability to control the output of any model using a grammar.
Read more
Report
Report
Generating levels in real time with the Jev model - Sprite Fusion
Generating game level design in realtime with TypeSafe Jev model using game state and structured decisions.
Read more
Report
Generate Capital Closes $117-Million in Financing for Community Solar
Generate Capital, a leading investor, owner and operator of critical infrastructure, on September 15 announced the closing of a $117-million term debt facility with MUFG to finance a portfolio of community solar projects. The transaction marks Generate's
Read more
Report
Generate Capital closes $117 million in community solar financing from MUFG
The term debt facility, which marks Generate's first community solar financing with the global financial group, will finance 18 community solar projects in Illinois and New York totaling 114 MWdc.
Read more
Report
Generate Biomedicines' IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug
Flagship Pioneering-founded Generate Biomedicines aims to offer less frequent injections compared to a blockbuster asthma drug from partners Amgen and AstraZeneca. Generate's drug comes from a
Read more
Report
Generate Capital appoints Sonneborn as president and Tsang as chief risk officer
Also, the firm has appointed Jonah Goldman as head of external affairs and impact, Mayanka Melville as head of data, and Aaron Bielenberg as head of portfolio management.
Read more
Report
Show more news
People

John Klein
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ

Longitude Capital 


